This year's flu vaccine guards against new strains

by Lauran Neergaard

(AP)—Time to get your flu vaccine. And remember: Last year's shot won't protect you this year.

said Thursday that this year's vaccine contains protection against two different that have begun circling the globe. And just because flu was mild last winter, doesn't mean it won't bounce back with its usual ferocity this winter.

With 135 million doses expected, there's plenty of vaccine to go around.

Flu vaccination is recommended for virtually everyone older than 6 months of age. But the government says just 42 percent of Americans were immunized last year.

The good news is that three-quarters of babies and toddlers were vaccinated. But even though people 65 and older also are at very high risk, just two-thirds were vaccinated.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Is a repeat flu shot needed? This fall, maybe not

May 27, 2011

(AP) -- Vaccine makers said this month they plan to make a record amount of flu vaccine for this fall and winter - enough for more than half the population. It's just not clear all those people will need ...

Time to get your flu shot, but just one this year

Aug 31, 2010

(AP) -- It's flu-shot season already, and for the first time health authorities are urging nearly everyone to get vaccinated. There is even a new high-dose version for people 65 or older.

Recommended for you

New system targets germs in donated blood plasma

22 hours ago

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

Judge halts Alzheimer's drug swap until July

Dec 16, 2014

A federal judge has ordered an Irish drug manufacturer to halt its plans to discontinue its widely used Alzheimer's medication, allegedly in an effort to drive patients to a newer patented drug.

India court blocks Bayer generic drug appeal

Dec 13, 2014

An Indian court has rejected German drug giant Bayer's bid to block a generic version of its blockbuster cancer treatment Nexavar by a local drugmaker, a move hailed by activists on Saturday.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.